POLYMORPHISM IN HYDROXYLATION OF MEPHENYTOIN AND HEXOBARBITAL STEREOISOMERS IN RELATION TO HEPATIC P-450 HUMAN-2

被引:63
作者
YASUMORI, T
MURAYAMA, N
YAMAZOE, Y
KATO, R
机构
[1] Department of Pharmacology, School of Medicine, Keio University, Tokyo
关键词
D O I
10.1038/clpt.1990.34
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Stereoselective 4′-hydroxylations of R-(-)-mephenytoin and S-(+)-mephenytoin and 3′-hydroxylation of R-(-)-hexobarbital and S-(+)-hexobarbital were determined in liver microsomes of 14 Japanese subjects who were extensive metabolizers of mephenytoin and in five Japanese subjects who were poor metabolizers of mephenytoin. Content of P-450 human-2 assessed by Western blots was correlated to microsomal S-(+)-mephenytoin 4′-hydroxylation, R-(-)-hexobarbital 3′α-hydroxylation, and S-(+)-hexobarbital 3′β-hydroxylation, and was less correlated to R-(-)-mephenytoin 4′-hydroxylation, R-(-)hexobarbital 3′β-hydroxylation, and S-(+)-hexobarbital 3′α-hydroxylation. Antibodies raised against P-450 human-2 inhibited microsomal S-(+)-mephenytoin 4′-hydroxylation efficiently but was less efficient on R-(-)-mephenytoin 4′-hydroxylation in extensive metabolizers and on 4′-hydroxylation of mephenytoin enantiomers in poor metabolizers. The antibodies also inhibited R-(-)-hexobarbital 3′α-hydroxylation and S-(+)-hexobarbital 3′(β-hydroxylation but did not effectively inhibit the hydroxylation of the two other optical isomers of hexobarbital in extensive metabolizers and of four stereoisomers in poor metabolizers. These findings indicate the close relationship between polymorphic mephenytoin 4′-hydroxylation and two stereospecific hexobarbital hydroxylations, and they suggest that P-450 human-2 is a typical S-(+)-mephenytoin 4′-hydroxylase and a major hexobarbital 3′-hydroxylase in the livers of extensive metabolizers. The findings were further supported by the experiments that used P-450 human-2 complementary dexoyribonucleic acid-derived protein in yeast microscomes. © 1990.
引用
收藏
页码:313 / 322
页数:10
相关论文
共 31 条
[1]   STEREOCHEMISTRY, A BASIS FOR SOPHISTICATED NONSENSE IN PHARMACOKINETICS AND CLINICAL-PHARMACOLOGY [J].
ARIENS, EJ .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 26 (06) :663-668
[3]   CHARACTERIZATION OF CDNAS, MESSENGER-RNAS, AND PROTEINS RELATED TO HUMAN-LIVER MICROSOMAL CYTOCHROME-P-450 (S)-MEPHENYTOIN 4'-HYDROXYLASE [J].
GED, C ;
UMBENHAUER, DR ;
BELLEW, TM ;
BORK, RW ;
SRIVASTAVA, PK ;
SHINRIKI, N ;
LLOYD, RS ;
GUENGERICH, FP .
BIOCHEMISTRY, 1988, 27 (18) :6929-6940
[4]   MEPHENYTOIN-TYPE POLYMORPHISM OF DRUG OXIDATION - PURIFICATION AND CHARACTERIZATION OF A HUMAN-LIVER CYTOCHROME-P-450 ISOZYME CATALYZING MICROSOMAL MEPHENYTOIN HYDROXYLATION [J].
GUT, J ;
MEIER, UT ;
CATIN, T ;
MEYER, UA .
BIOCHIMICA ET BIOPHYSICA ACTA, 1986, 884 (03) :435-447
[5]  
HALL SD, 1987, J PHARMACOL EXP THER, V240, P216
[6]   MEPHENYTOIN AND SPARTEINE PHARMACOGENETICS IN CANADIAN CAUCASIANS [J].
INABA, T ;
JURIMA, M ;
NAKANO, M ;
KALOW, W .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1984, 36 (05) :670-676
[7]   POLYMORPHIC METABOLISM OF MEPHENYTOIN IN MAN - PHARMACOKINETIC INTERACTION WITH A CO-REGULATED SUBSTRATE, MEPHOBARBITAL [J].
JACQZ, E ;
HALL, SD ;
BRANCH, RA ;
WILKINSON, GR .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 39 (06) :646-653
[8]   GENETIC-POLYMORPHISM OF MEPHENYTOIN P(4')-HYDROXYLATION - DIFFERENCE BETWEEN ORIENTALS AND CAUCASIANS [J].
JURIMA, M ;
INABA, T ;
KADAR, D ;
KALOW, W .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 19 (04) :483-487
[9]   PURIFICATION OF HUMAN-LIVER CYTOCHROME-P-450 CATALYZING TESTOSTERONE 6-BETA-HYDROXYLATION [J].
KAWANO, S ;
KAMATAKI, T ;
YASUMORI, T ;
YAMAZOE, Y ;
KATO, R .
JOURNAL OF BIOCHEMISTRY, 1987, 102 (03) :493-501
[10]   CDNA AND AMINO-ACID-SEQUENCES OF 2 MEMBERS OF THE HUMAN P450IIC GENE SUBFAMILY [J].
KIMURA, S ;
PASTEWKA, J ;
GELBOIN, HV ;
GONZALEZ, FJ .
NUCLEIC ACIDS RESEARCH, 1987, 15 (23) :10053-10054